The post is a summary of how things look today and under related reading I have included some past posts that may offer a few more details on how the shift it taking place today. Things are also happening and humming as well in China and you can search and find some recent relative posts here as...
Posted to
The Medical Quack .... by Barbara Duck
on 11-20-2008
Filed under: Pharma/FDA News, My Commentaries, healthcare, Pharma, clinical trials, R and D, India, Economics, Mayo Clinic, Outsourcing, Employment, China pharma
At first you may say this is old stuff, but the new version does much more than just take pictures on it’s way through your system, this one disperses medication, and that’s the whole idea is to have a pill put the medicine on target, where it needs to be with digestive problems such as treating Crohn...
Posted to
The Medical Quack .... by Barbara Duck
on 11-11-2008
Filed under: Medically Related, Technology, Pharma/FDA News, healthcare, Pharma, Phillips, iPill, digestive problems, crohn's disease
Will there be more Crestor for all? I am guessing the side effects of rising blood sugar levels still may need to be addressed, even with the report to determine which issue is more profound. With the cost of the product versus the generic version, this might also add some impact as to availability...
The general public as a whole are lost when it comes to the complete understanding of how a clinical trial can benefit their potential treatment plans. There is enough information on the web by all means, but how do you get the information to an individual and explain both the potential benefits...
Posted to
The Medical Quack .... by Barbara Duck
on 11-07-2008
Filed under: Medically Related, Technology, drugs, healthcare, EHR, Pharma, PHR, clinical trials, Software integration, Point of Care, Personalized Clinical Trials
New abbreviation here to become acquainted with (PGx) which is pharmacogenics, and one more move in the direction of personalized medicine by big Pharma as the marketing of blockbuster drugs slowly evolves to a new business model with genomic data input becoming a part of the process to bring new drugs...
Posted to
The Medical Quack .... by Barbara Duck
on 11-06-2008
Filed under: Medically Related, Technology, personalized medicine, Genomics, healthcare, Pharma, Pharmacogenomics, Lilly, Pharmacogenetics
This particular statement really bothers me, is CMS now going to take on the role of “doctor here? “ The Bush administration argued that Medicare officials had the right to decide whether the expense incurred for a given item, not just the item itself, was “reasonable and necessary.” How...
Posted to
The Medical Quack .... by Barbara Duck
on 11-04-2008
Filed under: Medically Related, Insurance, My Commentaries, healthcare, Pharma, Congress, CMS, Medicare contractor, Drug costs, Federal Court
I will once more mention a potential change of paradigms here with educating the public. Each patient who took the drug is unique. Do we have any information on other drugs they were taking at the same time? Groups will continue to advise against the use until the full facts are known...
Posted to
The Medical Quack .... by Barbara Duck
on 10-31-2008
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, drugs, healthcare, Pharma, PHR, FDA, Marketing, paradigms, personal heatlh records